Sort   by:  
 Page size 
UnknownExtracellular Vesicle Proteomes Shed Light on the Evolutionary, Interactive, and Functional Divergence of Their Biogenesis Mechanisms.
Not available
S-EPMC8517337 | biostudies-literature
UnknownNew sources of drugs for hematologic malignancies.
Not available
S-EPMC3357971 | biostudies-literature
UnknownMultisite clinical cross-validation and variant interpretation of a next generation sequencing panel for lymphoid cancer prognostication.
Not available
S-EPMC11874376 | biostudies-literature
UnknownAssociation between duration of smoking abstinence before non-small-cell lung cancer diagnosis and survival: a retrospective, pooled analysis of cohort studies.
Not available
S-EPMC10540150 | biostudies-literature
UnknownA Small Molecule Targeting Mutagenic Translesion Synthesis Improves Chemotherapy.
Not available
S-EPMC6644000 | biostudies-literature
UnknownInterleukin-12 anchored drug conjugate (tolododekin alfa) in patients with advanced solid tumors: first-in-human Phase 1 trial.
Not available
S-EPMC12480005 | biostudies-literature
UnknownTumor-specific cholinergic CD4<sup>+</sup> T lymphocytes guide immunosurveillance of hepatocellular carcinoma.
Not available
S-EPMC10597839 | biostudies-literature
UnknownThe Shb scaffold binds the Nck adaptor protein, p120 RasGAP, and Chimaerins and thereby facilitates heterotypic cell segregation by the receptor EphB2.
Not available
S-EPMC7086039 | biostudies-literature
UnknownEfficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial.
Not available
S-EPMC5070559 | biostudies-literature
UnknownFinal safety and efficacy results from a phase 1/2 study of tagraxofusp, a CD123-targeted therapy, for myelofibrosis.
Not available
S-EPMC12554100 | biostudies-literature
Sort   by:  
 Page size